CORMEDIX, INC.
BRIDGEWATER, NJ · Founded 2006 · CIK 0001410098 · Biotech · Public
Antimicrobial catheter lock solution to prevent bloodstream infections in dialysis and central venous catheters
cormedix.com →- Grants
- $281K
- 2 awards
- Sector median: 1
- Raised
- $3.5M
- 2 Form D · Oct 2012
- 169 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 7 granted · 33 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓200920112013201520172019
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $2,619,973 | |
| Private capital raised | Form D · SEC | $850,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of a novel combination of anti-septic taurolidine encased in a digestible nanoparticle system for use as topical treatment at burn sites | $224,378 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of a novel combination of anti-septic taurolidine encased in a digestible nanoparticle system for use as topical treatment at burn sites | $57,116 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 3358 | True North Therapeutics | — | — |
| 3359 | Neomorph | — | — |
| 3360 | ALPHAMEMORY, LLC | — | — |
| 3361 | CORMEDIX, INC. | — | $3.5M |
| 3362 | ACTINOBAC BIOMED, INC. | — | $3.4M |
| 3363 | Vernal Biosciences, Inc. | — | $22M |
| 3364 | AVICANNA INC. | — | $10M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Richard CohenDirector · Executive Officer
- Bruce CooperDirector
- Matthew DuffyDirector
- Russell EllisonDirector
- Gary GelbfishDirector
- Timothy HoferDirector
- John HoughtonDirector · Executive Officer
- Mark HouserExecutive Officer
- Steven LefkowitzDirector
- Randy MilbyExecutive Officer
- Mahendra PatelDirector
- Anthony PfaffleDirector
- Antony PfaffleDirector
- Stephen PilatzkeExecutive Officer
- Lindsay RosenwaldPromoter
Patents
- Antimicrobial Compositions, Including Antimicrobial Hydrogels, Effective Against Mature Biofilmsapplication
- Improved Synthesis of Taurolidine, Purity Profiles and Polymorphsapplication
- Antimicrobial Compositions, Including Antimicrobial Hydrogels, Effective Against Mature Biofilmsgranted
- Taurolidine Treatment For Myc-expressing Tumors In Mammalian Bodiesapplication
- Methods And Pharmaceutical Compositions For Treating Candida Auris In Bloodapplication
- Taurultam, Taurinamide And Methylene Glycol Treatment For Myc-expressing Tumors In Mammalian Bodiesgranted
- Methods And Pharmaceutical Compositions For Treating Candida Auris In Bloodgranted
- Neuroblastoma Treatment With Taurolidine Hydrolysis Productsapplication
- Synthesis Of Taurolidine, Purity Profiles And Polymorphsgranted
- Neuroblastoma Treatment With Taurolidine Hydrolysis Productsgranted
- Therapeutic Nanoparticles For The Treatment Of Neuroblastoma And Other Cancersapplication
- Skin-penetrating Formulation Of Taurolidineapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.